Vella A - Search Results

1

Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.

Smushkin G, Sathananthan M, Sathananthan A, Dalla Man C, Micheletto F, Zinsmeister AR, Cobelli C, Vella A. Smushkin G, et al. Among authors: vella a. Diabetes. 2012 May;61(5):1082-9. doi: 10.2337/db11-1732. Epub 2012 Mar 28. Diabetes. 2012. PMID: 22461567 Free PMC article.

2

Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition.

Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Samsom M, et al. Among authors: vella a. Am J Physiol Gastrointest Liver Physiol. 2000 Jun;278(6):G946-51. doi: 10.1152/ajpgi.2000.278.6.G946. Am J Physiol Gastrointest Liver Physiol. 2000. PMID: 10859225 Free article. Clinical Trial.

3

Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.

Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA. Basu A, et al. Among authors: vella a. Diabetes. 2000 Feb;49(2):272-83. doi: 10.2337/diabetes.49.2.272. Diabetes. 2000. PMID: 10868944

4

Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.

Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA. Vella A, et al. Diabetes. 2000 Apr;49(4):611-7. doi: 10.2337/diabetes.49.4.611. Diabetes. 2000. PMID: 10871199 Clinical Trial.

5

Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Shah P, et al. Among authors: vella a. J Clin Endocrinol Metab. 2000 Nov;85(11):4053-9. doi: 10.1210/jcem.85.11.6993. J Clin Endocrinol Metab. 2000. PMID: 11095432

6

Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.

Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Vella A, et al. Diabetes. 2001 Mar;50(3):565-72. doi: 10.2337/diabetes.50.3.565. Diabetes. 2001. PMID: 11246876

7

Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity.

Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA. Basu A, et al. Among authors: vella a. Diabetes. 2001 Jun;50(6):1351-62. doi: 10.2337/diabetes.50.6.1351. Diabetes. 2001. PMID: 11375336

8

Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.

Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Vella A, et al. Diabetologia. 2001 Jun;44(6):729-37. doi: 10.1007/s001250051682. Diabetologia. 2001. PMID: 11440366

9

Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.

Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Shah P, et al. Among authors: vella a. Diabetes. 2002 Feb;51(2):301-10. doi: 10.2337/diabetes.51.2.301. Diabetes. 2002. PMID: 11812736

10

Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus.

Vella A, Lee JS, Camilleri M, Szarka LA, Burton DD, Zinsmeister AR, Rizza RA, Klein PD. Vella A, et al. Neurogastroenterol Motil. 2002 Apr;14(2):123-31. doi: 10.1046/j.1365-2982.2002.00311.x. Neurogastroenterol Motil. 2002. PMID: 11975712 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

686 results

Search Page

Filters